在巨细胞动脉炎中,基酸莫菲蒂尔
Anne Pankow1,2, Sena Sinno2, Thorsten Derlin3
1Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Frontiers in medicine
|November 29, 2023
概括
菌酸莫菲提尔 (MMF) 在患有巨细胞动脉炎 (GCA) 的患者中有效诱导缓解. 这种淋巴细胞特异性免疫抑制疗法在一系列病例中显示了降低CRP水平和持续的疾病控制.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 巨细胞动脉炎 (GCA) 是一种系统性血管炎,影响大动脉,淋巴细胞功能异常与其致病症有关.
- 菌酸莫菲提尔 (MMF) 是一种针对淋巴细胞特异性免疫抑制剂,向因氨酸单酸脱酶.
研究的目的:
- 评估Mycophenolate mofetil (MMF) 在被诊断为巨细胞关节炎 (GCA) 的患者中实现疾病缓解的疗效.
主要方法:
- 在2010年至2023年期间,七名GCA患者接受MMF治疗的回顾性病例系列.
- 通过双重超声波,18F-FDG PET,MRI和/或活检确认诊断.
- 主要终点包括复发率,3-6个月和6-12个月的CRP水平以及缓解持续时间.
主要成果:
- 所有患者都表现出动脉血管的炎症活性,通过成像或活检得到证实.
- 在MMF开始后的3-6个月和6-9个月,C-反应蛋白 (CRP) 水平显著下降.
- 在研究期间,所有七名患者的疾病完全缓解.
结论:
- 菌酸莫菲蒂尔 (MMF) 是一种有希望的有效治疗方法,可以控制巨细胞关节炎 (GCA) 的疾病活性.
- 通过随机对照试验进行进一步的调查是有必要的,以证实这些发现.
更多相关视频
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.2K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168